[HTML][HTML] Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects
RAMAR Vieira, EM Minicucci, MEA Marques… - Anais brasileiros de …, 2012 - SciELO Brasil
Actinic cheilitis is the main precancerous lesion of the lip. Squamous cell carcinoma of the
lip is reported together with oral carcinomas in the Brazilian official statistics. Overall, they …
lip is reported together with oral carcinomas in the Brazilian official statistics. Overall, they …
[HTML][HTML] Head and neck cancer pain: systematic review of prevalence and associated factors
TV Macfarlane, T Wirth, S Ranasinghe… - Journal of oral & …, 2012 - ncbi.nlm.nih.gov
Head and Neck Cancer Pain: Systematic Review of Prevalence and Associated Factors - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers
AB Miah, SA Bhide, MT Guerrero-Urbano… - International Journal of …, 2012 - Elsevier
PURPOSE: To determine the safety and outcomes of induction chemotherapy followed by
dose-escalated intensity-modulated radiotherapy (IMRT) with concomitant chemotherapy in …
dose-escalated intensity-modulated radiotherapy (IMRT) with concomitant chemotherapy in …
[HTML][HTML] Expression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma
MB Cai, HQ Han, JX Bei, CC Liu, JJ Lei… - … journal of biological …, 2012 - ncbi.nlm.nih.gov
Human leukocyte antigen G (HLA-G) has multiple immune regulatory functions including the
induction of immune tolerance in malignancies. The roles of HLA-G have not been …
induction of immune tolerance in malignancies. The roles of HLA-G have not been …
Prognostic impact of the level of neck metastasis in oral cancer patients
HF Köhler, LP Kowalski - Brazilian journal of otorhinolaryngology, 2012 - SciELO Brasil
Neck staging in oral cancer depends on the number of compromised nodes, their size and
side of occurrence. Objective: This paper aims to evaluate risk factors for metastatic nodes in …
side of occurrence. Objective: This paper aims to evaluate risk factors for metastatic nodes in …
Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma
MA Pavon, M Parreno, M Tellez-Gabriel… - …, 2012 - academic.oup.com
The purpose of this study was to identify molecular markers associated with tumor
recurrence and survival in patients with locally advanced head and neck squamous cell …
recurrence and survival in patients with locally advanced head and neck squamous cell …
Oral cavity squamous cell carcinoma metastasis to the submandibular gland
TK Naidu, SK Naidoo, PK Ramdial - The Journal of Laryngology & …, 2012 - cambridge.org
Introduction: This study aimed to evaluate the incidence of submandibular gland metastases
in cases of oral cavity squamous cell carcinoma. Methods: Sixty-nine patients treated …
in cases of oral cavity squamous cell carcinoma. Methods: Sixty-nine patients treated …
[PDF][PDF] HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated
Abstract Background: HER2/neu, a member of EGFR family, is over expressed in some
tumors. The purpose of this study was to determine the salivary level and tissue expression …
tumors. The purpose of this study was to determine the salivary level and tissue expression …
[PDF][PDF] Associações entre fatores de risco e complicações bucais em pacientes com câncer de cabeça e pescoço tratados com radioterapia associada ou não à …
AC Bueno, CS Magalhães, AN Moreira - Pesquisa Brasileira em …, 2012 - redalyc.org
Objetivo: Descrever as reações adversas que ocorreram em pacientes durante a
radioterapia associada ou não à quimioterapia, bem como avaliar suas possíveis …
radioterapia associada ou não à quimioterapia, bem como avaliar suas possíveis …
Molecular characterization of head and neck cancer: how close to personalized targeted therapy?
MJ Worsham, H Ali, J Dragovic… - Molecular diagnosis & …, 2012 - Springer
Molecular targeted therapy in head and neck squamous cell carcinoma (HNSCC) continues
to make strides, and holds much promise. Cetuximab remains the sole US FDA-approved …
to make strides, and holds much promise. Cetuximab remains the sole US FDA-approved …